PC
PCRX icon

Pier Capital’s Pacira BioSciences PCRX Stock Holding History

Pier Capital’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-74,938
Closed -$5.75M – 125
2015
Q4 		$5.75M Buy
+74,938
New +$4.24M 1% 60
2015
Q1 		– Sell
-34,084
Closed -$3.02M – 117
2014
Q4 		$3.02M Sell
34,084
-31,029
-48% -$2.94M 0.45% 96
2014
Q3 		$6.31M Sell
65,113
-30,235
-32% -$2.94M 1.01% 55
2014
Q2 		$8.76M Sell
95,348
-37,109
-28% -$2.83M 1.24% 16
2014
Q1 		$9.27M Sell
132,457
-1,424
-1% -$96.9K 1.19% 14
2013
Q4 		$7.7M Sell
133,881
-64,798
-33% -$3.41M 1.03% 44
2013
Q3 		$9.55M Sell
198,679
-35,450
-15% -$1.29M 1.35% 8
2013
Q2 		$6.79M Buy
+234,129
New +$6.77M 1.04% 47

Other funds holding PCRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return